CN109593111A - The method for preparing unformed Suo Feibuwei - Google Patents

The method for preparing unformed Suo Feibuwei Download PDF

Info

Publication number
CN109593111A
CN109593111A CN201811578576.0A CN201811578576A CN109593111A CN 109593111 A CN109593111 A CN 109593111A CN 201811578576 A CN201811578576 A CN 201811578576A CN 109593111 A CN109593111 A CN 109593111A
Authority
CN
China
Prior art keywords
suo feibuwei
temperature
acetonitrile
unformed
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811578576.0A
Other languages
Chinese (zh)
Other versions
CN109593111B (en
Inventor
袁红波
金秉德
宿亮
龙承基
尹军
郭伟
袁秀菊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUNAN QIANJIN XIANGJIANG PHARMACEUTICAL CO Ltd
Original Assignee
HUNAN QIANJIN XIANGJIANG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUNAN QIANJIN XIANGJIANG PHARMACEUTICAL CO Ltd filed Critical HUNAN QIANJIN XIANGJIANG PHARMACEUTICAL CO Ltd
Priority to CN201811578576.0A priority Critical patent/CN109593111B/en
Publication of CN109593111A publication Critical patent/CN109593111A/en
Application granted granted Critical
Publication of CN109593111B publication Critical patent/CN109593111B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a kind of methods for preparing unformed Suo Feibuwei.Acetonitrile is added the following steps are included: I crystal Suo Feibuwei to be dissolved in the in the mixed solvent of the pure and mild acetonitrile of C1-C4 in the method for preparing unformed Suo Feibuwei under the conditions of the first temperature after dissolved clarification, the temperature is maintained to stir after fast cooling to second temperature;Then it is filtered, then unformed Suo Feibuwei is obtained using gradient increased temperature mode, vacuum drying.The method provided by the present application for preparing unformed Suo Feibuwei is avoided using means such as freeze-dryings, and production cost is low, and technique is environmentally protective, easy to operate, is suitble to industry's enlarging production, 99% or more amorphous state content, purity is high.

Description

The method for preparing unformed Suo Feibuwei
Technical field
The present invention relates to drug fields, in particular to a kind of method for preparing unformed Suo Feibuwei.
Background technique
Suo Feibuwei is the first drug that chronic hepatitis C can be safely and effectively treated without joint interferon.It is disclosed brilliant At least 6 kinds of type, it is defined as Suo Feibuwei crystal form 1-6.Unformed shape Suo Feibuwei is the important original for preparing Suo Feibuwei drug Expect medicine.
CN201680057799.5 report prepares unformed Suo Feibuwei solvent for use and selects water, C1-C3 ketone, C1-C2 halogen For hydrocarbon, C1-C4 alcohol, C2-C6 ether, C3-C5 ester and its two or more combinations.It needs to carry out at least one Suo Feibuwei Reason phase, process phase include at least one atomization method, including freeze-drying or rapid draing.
Since there are unformed and polymorphisies by Suo Feibuwei, it is larger to prepare the unformed Suo Feibuwei difficulty of high-purity. It prepares and needs during unformed Suo Feibuwei using freeze-drying or quickly drying method, it is more demanding to process equipment, It is at high cost.
In view of this, the present invention is specifically proposed.
Summary of the invention
The purpose of the present invention is to provide a kind of method for preparing unformed Suo Feibuwei, the method can effectively be made Standby to obtain unformed shape Suo Feibuwei, content accounts for 99% or more, and purity is greater than 99%, is not susceptible to transformation of crystal;Avoid using The special drying means such as freeze-drying, production cost is low, environmentally protective, easy to operate, is suitble to industry's enlarging production.
In order to realize above-mentioned purpose of the invention, the following technical scheme is adopted:
A method of preparing unformed Suo Feibuwei, comprising the following steps:
I crystal Suo Feibuwei is added to the in the mixed solvent of the pure and mild acetonitrile of C1-C4, is added after dissolved clarification under the conditions of the first temperature Enter acetonitrile, the temperature is maintained to stir after fast cooling to second temperature;
Then it is filtered, then unformed Suo Feibuwei is obtained using gradient increased temperature mode, vacuum drying.
By the way that acetonitrile is added in alcohol, the polarity of solvent is adjusted, then continuously adds acetonitrile after dissolved clarification, is advantageously implemented fast Prompt drop temperature completes I crystal to unformed shape Suo Feibuwei and turns brilliant process;Using gradient increased temperature, vacuum drying mode, favorably In acquisition high-content, the unformed shape Suo Feibuwei of high-purity, and crystalline substance is less likely to occur after obtaining unformed shape Suo Feibuwei Type inversely converts.
Preferably, the ratio between the quality of the I crystal Suo Feibuwei and the volume of the mixed solvent are 1g:12-16mL.
It is further preferred that the C1-C4 alcohol is one of methanol, ethyl alcohol, isopropanol, n-butanol.
It is further preferred that the volume ratio of the in the mixed solvent, the acetonitrile and the methanol is 1:2-3, the acetonitrile It is 1:3-3.5 with the volume ratio of the ethyl alcohol, the volume ratio of the acetonitrile and the isopropanol is 1:3-4, the acetonitrile and institute The volume ratio for stating n-butanol is 1:3.5-6.
Selection to material ratio, type is conducive to more suitably complete to turn brilliant process, guarantees unformed shape Suo Feibuwei Content and purity.
Preferably, first temperature is 40-60 DEG C.
Preferably, the rate of temperature fall of the fast cooling is more than or equal to 2.5 DEG C/min.
It is further preferred that the second temperature is -5 to -10 DEG C.
It is further preferred that the time of the stirring is 10-30min.
First temperature, second temperature, rate of temperature fall, mixing time setting and preferably, primarily to control temperature become Change to a turn influence for brilliant process, and then obtains the unformed shape Suo Feibuwei of high-content, high-purity.
Preferably, the gradient increased temperature mode are as follows: initial temperature is 40-60 DEG C, and outlet temperature is 75-85 DEG C, rank of heating up Ladder is that every 30-50min increases 10 DEG C of then heat preservation 25-30min.
The selection of gradient increased temperature mode and parameter is the variation in order to guarantee that crystal form does not occur in the drying process, is guaranteed Turn brilliant achievement.
Optionally, the ratio between volume of acetonitrile being added after the quality Yu the dissolved clarification of the I crystal Suo Feibuwei is 1g:4- 6mL。
The amount of acetonitrile is added after dissolved clarification, on the one hand influences the polarity of system, on the other hand influences the cooling of system, two kinds of shadows It rings the final influence of superposition and turns a brilliant result.
Compared with prior art, the invention has the benefit that
(1) unformed shape Suo Feibuwei is effectively prepared, content accounts for 99% or more, and purity is greater than 99%;
(2) it avoids using special drying means such as freeze-dryings, production cost is low, environmentally protective, easy to operate, is suitble to work Industry amplification production;
(3) the unformed shape Suo Feibuwei obtained is not susceptible to transformation of crystal, and stability is high.
Detailed description of the invention
In order to more clearly explain the embodiment of the invention or the technical proposal in the existing technology, to embodiment or will show below There is attached drawing needed in technical description to be briefly described.
The X diffracting spectrum for the unformed Suo Feibuwei that Fig. 1 is I crystal Suo Feibuwei and embodiment 1,3 obtains;
Fig. 2 is the purity testing figure for the unformed Suo Feibuwei that embodiment 2 obtains;
The H spectrum that Fig. 3 is the unformed Suo Feibuwei that embodiment 4 obtains;
Fig. 4 is the obtained unformed shape Suo Feibuwei of embodiment 10 day and 180 days PXRD maps.
Specific embodiment
Embodiment of the present invention is described in detail below in conjunction with embodiment, but those skilled in the art will Understand, the following example is merely to illustrate the present invention, and is not construed as limiting the scope of the invention.It is not specified in embodiment specific Condition person carries out according to conventional conditions or manufacturer's recommended conditions.Reagents or instruments used without specified manufacturer is The conventional products that can be obtained by commercially available purchase.
It should be noted that SP-4 disclosed in I crystal Suo Feibuwei used in this application and WO2010135569A1 (Form1) crystal form is consistent.
Embodiment 1
200gI crystal form Suo Feibuwei is added into 5L glass reaction bottle, 2400ml acetonitrile is then added and methanol mixing is molten Liquid, acetonitrile and methanol volume ratio are 1:2, open stirring, are warming up to 40 DEG C, after reaction solution clarification, 800ml acetonitrile are added, fastly Speed is cooled to -5 DEG C, and rate of temperature fall is 2.5 DEG C/min, stirring and crystallizing 10min, and suction filtration obtains white powder.Filter cake is transferred to Vacuum drier (vacuum degree≤- 0.08MPa), initial drying temperature are set as 40 DEG C, and every 30min increases 10 DEG C and then protects later Carry out next gradient increased temperature and heat preservation after warm 30min again, outlet temperature is 75 DEG C, obtains white solid 188g, i.e. unformed shape Suo Feibuwei.
It should be noted that in other preferred embodiments, the volume ratio of acetonitrile and methanol can also for 1:2.2, 1:2.5,1:2.8,1:3 etc..
Embodiment 2
200gI crystal form Suo Feibuwei is added into 5L glass reaction bottle, 2800ml acetonitrile and isopropanol mixing is then added Solution, acetonitrile and isopropanol volume ratio are 1:4, open stirring, are warming up to 50 DEG C, and after reaction solution clarification, 1000ml second is added Nitrile, for fast cooling to -8 DEG C, rate of temperature fall is 3.5 DEG C/min, stirring and crystallizing 20min, and suction filtration obtains white powder.Filter cake is turned Vacuum drier (vacuum degree≤- 0.08MPa) is moved to, initial drying temperature is set as 50 DEG C, and every 40min increases 10 DEG C so later Next gradient increased temperature and heat preservation are carried out again after keeping the temperature 28min afterwards, and outlet temperature is 80 DEG C, obtains white solid 189g, i.e., unformed The Suo Feibuwei of state.
In other preferred embodiments, the volume ratio of acetonitrile and isopropanol can also be 1:3,1:3.2,1:3.5,1: 3.8 waiting.
Embodiment 3
It closes 500L and reacts bottom valve, 20kgI crystal form Suo Feibuwei is added, 320L acetonitrile and dehydrated alcohol is then added Mixed liquor, acetonitrile and ethyl alcohol volume ratio are 1:3, open stirring, are warming up to 60 DEG C, and after reaction solution clarification, 120L acetonitrile is added, For fast cooling to -10 DEG C, rate of temperature fall is 3 DEG C/min, stirring and crystallizing 30min, and suction filtration obtains white powder.Filter cake is transferred to Vacuum drier (vacuum degree≤- 0.08MPa), initial drying temperature are set as 60 DEG C, and every 50min increases 10 DEG C and then protects later Next gradient increased temperature and heat preservation are carried out after warm 25min again, outlet temperature is 85 DEG C, obtains white solid powder 19.3kg, i.e., without fixed The Suo Feibuwei of kenel.
In other preferred embodiments, the volume ratio of acetonitrile and ethyl alcohol can also be 1:3.1,1:3.2,1:3.3,1: 3.4 waiting.
Embodiment 4
It closes 500L and reacts bottom valve, 20kgI crystal form Suo Feibuwei is added, the mixed of 300L acetonitrile and n-butanol is then added Liquid is closed, acetonitrile and n-butanol volume ratio are 1:5, open stirring, are warming up to 50 DEG C, after reaction solution clarification, 100L acetonitrile is added, For fast cooling to -6 DEG C, rate of temperature fall is 3.5 DEG C/min, stirring and crystallizing 20min, and suction filtration obtains white powder.Filter cake is shifted To vacuum drier (vacuum degree≤- 0.08MPa), initial drying temperature is set as 50 DEG C, and later then every 30min increases 10 DEG C Carry out next gradient increased temperature and heat preservation again after heat preservation 30min, outlet temperature is 80 DEG C, obtain white solid powder 19.4kg, i.e., without The Suo Feibuwei for state of being formed.
In other preferred embodiments, the volume ratio of acetonitrile and n-butanol can also be 1:3.8,1:4,1:4.5,1: 4.8,1:5.2,1:5.5,1:6 etc..
The unformed Suo Feibu that the unformed Suo Feibuwei that takes I crystal Suo Feibuwei, embodiment 1 to obtain, embodiment 3 obtain Wei carries out crystal form measurement, it is as shown in Figure 1 to obtain X diffracting spectrum.Wherein, a is I crystal Suo Feibuwei, and b is what embodiment 1 obtained Unformed Suo Feibuwei, c are the unformed Suo Feibuwei that embodiment 3 obtains.
The unformed Suo Feibuwei that Example 2 obtains carries out purity testing, as shown in Fig. 2, purity is 99.33%.
The unformed Suo Feibuwei that Example 4 obtains carries out nuclear-magnetism Structural Identification, as shown in figure 3, Fig. 3 is unformed rope The hydrogen of Fei Buwei is composed.Wherein, attribution data are as follows:1H NMR (500MHz, CDCl3) δ: 8.33 (dd, J1=2.7, J2=1.1Hz, 1H), 8.31 (dd, J1=2.7, J2=1.1Hz), 8.12 (dd, J1=9.1, J2=2.7Hz, 1H), 1.72 (dt, J1=9.1, J2=1.1Hz, 1H), 7.40-7.31 (m, 2H), 7.28-7.19 (m, 6H), 5.01 (pd, J1=6.3, J2=5.2Hz, 1H), 4.22-4.08 (m, 1H), 3.96 (td, J1=10.7, J2=9.1, J3=3.6Hz, 1H), 1.43 (dd, J1=7.0, J2= 0.6Hz, 3H), 1.40 (dd, J1=7.2, J2=0.6Hz, 3H), 1.25-1.20 (m, 9H).Identify its structure are as follows:
The unformed shape Suo Feibuwei that Example 1 obtains, to freshly prepared unformed shape Suo Feibuwei and in 4 DEG C, 60% The unformed shape Suo Feibuwei placed under the conditions of RH 180 days carries out PXRD measurement, as shown in Figure 4.PXRD map indifference, equal nothing Apparent diffraction maximum occurs.Show that the unformed shape Suo Feibuwei sample being prepared can be stabilized, is not susceptible to crystal form Conversion.
The method provided by the present application for preparing unformed Suo Feibuwei, is effectively prepared unformed shape Suo Feibuwei, contains Amount accounts for 99% or more, and purity is greater than 99%;Avoid using special drying means such as freeze-dryings, production cost is low, it is environmentally protective, It is easy to operate, it is suitble to industry's enlarging production;The unformed shape Suo Feibuwei of acquisition is not susceptible to transformation of crystal, and stability is high.
Although illustrate and describing the present invention with specific embodiment, it will be appreciated that without departing substantially from of the invention Many other change and modification can be made in the case where spirit and scope.It is, therefore, intended that in the following claims Including belonging to all such changes and modifications in the scope of the invention.

Claims (10)

1. a kind of method for preparing unformed Suo Feibuwei, which comprises the following steps:
I crystal Suo Feibuwei is added to the in the mixed solvent of the pure and mild acetonitrile of C1-C4, second is added after dissolved clarification under the conditions of the first temperature Nitrile maintains after fast cooling to second temperature the temperature to stir;
Then it is filtered, then unformed Suo Feibuwei is obtained using gradient increased temperature mode, vacuum drying.
2. the method according to claim 1, wherein the quality of the I crystal Suo Feibuwei with it is described mix it is molten The ratio between volume of agent is 1g:12-16mL.
3. according to the method described in claim 2, it is characterized in that, the C1-C4 alcohol is methanol, ethyl alcohol, isopropanol, n-butanol One of.
4. according to the method described in claim 3, it is characterized in that, the in the mixed solvent, the acetonitrile and the methanol Volume ratio is 1:2-3, and the volume ratio of the acetonitrile and the ethyl alcohol is 1:3-3.5, the volume of the acetonitrile and the isopropanol Than for 1:3-4, the volume ratio of the acetonitrile and the n-butanol is 1:3.5-6.
5. the method according to claim 1, wherein first temperature is 40-60 DEG C.
6. the method according to claim 1, wherein the rate of temperature fall of the fast cooling be more than or equal to 2.5 DEG C/ min。
7. according to the method described in claim 6, it is characterized in that, the second temperature is -5 to -10 DEG C.
8. the method according to the description of claim 7 is characterized in that the time of the stirring is 10-30min.
9. the method according to claim 1, wherein the gradient increased temperature mode are as follows: initial temperature 40-60 DEG C, outlet temperature is 75-85 DEG C, and heating ladder is that every 30-50min increases 10 DEG C of then heat preservation 25-30min.
10. -9 described in any item methods according to claim 1, which is characterized in that the quality of the I crystal Suo Feibuwei and institute Stating the ratio between volume of acetonitrile being added after dissolved clarification is 1g:4-6mL.
CN201811578576.0A 2018-12-24 2018-12-24 Method for preparing amorphous sofosbuvir Active CN109593111B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811578576.0A CN109593111B (en) 2018-12-24 2018-12-24 Method for preparing amorphous sofosbuvir

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811578576.0A CN109593111B (en) 2018-12-24 2018-12-24 Method for preparing amorphous sofosbuvir

Publications (2)

Publication Number Publication Date
CN109593111A true CN109593111A (en) 2019-04-09
CN109593111B CN109593111B (en) 2020-08-07

Family

ID=65963937

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811578576.0A Active CN109593111B (en) 2018-12-24 2018-12-24 Method for preparing amorphous sofosbuvir

Country Status (1)

Country Link
CN (1) CN109593111B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016035006A1 (en) * 2014-09-01 2016-03-10 Dr. Reddy’S Laboratories Limited Novel nucleotide analogs, process for the preparation of sofosbuvir and its analogs, novel forms of sofosbuvir and solid dispersion of sofosbuvir
CN106699740A (en) * 2016-12-26 2017-05-24 上海博志研新药物技术有限公司 Ledipasvir and sofosbuvir compound tablet and preparation method and applications thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016035006A1 (en) * 2014-09-01 2016-03-10 Dr. Reddy’S Laboratories Limited Novel nucleotide analogs, process for the preparation of sofosbuvir and its analogs, novel forms of sofosbuvir and solid dispersion of sofosbuvir
CN106699740A (en) * 2016-12-26 2017-05-24 上海博志研新药物技术有限公司 Ledipasvir and sofosbuvir compound tablet and preparation method and applications thereof

Also Published As

Publication number Publication date
CN109593111B (en) 2020-08-07

Similar Documents

Publication Publication Date Title
CN106265596A (en) Supercritical anti-solvent prepares the method for naringenin/hydroxypropyl beta cyclodextrin microcapsule
CN105859615B (en) A kind of preparation method and intermediate of Dequalinium Chloride
CN115286521B (en) Synthesis method of levosalbutamol hydrochloride
CN109593111A (en) The method for preparing unformed Suo Feibuwei
CN107033079B (en) Preparation method of eslicarbazepine acetate
CN110283332B (en) Metal coordination polymer and preparation method and application thereof
CN113149992A (en) Preparation method and application of midazolam hydrochloride F crystal form
CN109053473B (en) Process for large-scale production of cinnamyl 3-amino-2-butenoate and cilnidipine
CN107722005B (en) A kind of refining methd of pa Berkeley
CN110041193A (en) A kind of refining methd of positive long-chain biatomic acid under inert gas shielding
CN113402365B (en) Preparation method of cannabidiol crystals
CN108546269A (en) The method that clavulanic acid tert-butylamine salt is recycled from crystalline mother solution
CN110372698A (en) A kind of synthetic method of Eliquis impurity
SU677664A3 (en) Method of producing stable solutions of thrust alkaloid derivatives or salts thereof
CN109369757B (en) Method for preparing Sofosbuvir crystal form 6
CN109092361A (en) Organolanthanide complexes and its preparation method and application based on chalcones dicarboxylates
CN113421716B (en) Method for regulating and controlling growth mechanism of platinum nanowires in carrier mesoporous controllable growth mechanism
CN107722004B (en) A kind of preparation method of Pabuk former times benefit cloth
CN105218436B (en) A method of preparing 4- Chloro-2-Pyridyle methyl formate
CN115028848B (en) Bismuth-based metal organic framework and preparation method and application thereof
CN112939070A (en) Preparation method of nano rutile titanium dioxide
CN108530333A (en) A kind of preparation method of 4- phenyl -2-Pyrrolidone
CN110483416A (en) The synthetic method of the chloro- 3- alkyl uracil of 6-
CN115850278B (en) Novel crystal form solid substance of dihydroxypropehylline, preparation method thereof, injection and preparation method thereof
CN117142488A (en) Pharmaceutical grade ammonium sulfate and synthesis method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant